GE HealthCare Technologies (GEHC) – Analysts’ Recent Ratings Updates

GE HealthCare Technologies (NASDAQ: GEHC) recently received a number of ratings updates from brokerages and research firms:

• 8/19/2026 – GE HealthCare Technologies had its “buy” rating reaffirmed by BTIG Research. They now have a $79.00 price target on the stock.
• 8/12/2026 – GE HealthCare Technologies had its “hold (c-)” rating reaffirmed by Weiss Ratings.
• 8/11/2026 – GE HealthCare Technologies was upgraded by Zacks Research from “strong sell” to “hold”.
• 7/31/2026 – GE HealthCare Technologies had its price target raised by UBS Group AG from $67.00 to $73.00. They now have a “neutral” rating on the stock.
• 7/30/2026 – GE HealthCare Technologies had its “outperform” rating reaffirmed by Evercore Inc. They now have a $84.00 price target on the stock.
• 7/30/2026 – GE HealthCare Technologies had its “outperform” rating reaffirmed by Oppenheimer Holdings, Inc..
• 7/30/2026 – GE HealthCare Technologies had its price target raised by Citigroup Inc. from $69.00 to $75.00. They now have a “neutral” rating on the stock.
• 7/30/2026 – GE HealthCare Technologies had its price target raised by Wells Fargo & Company from $75.00 to $85.00. They now have an “overweight” rating on the stock.
• 7/29/2026 – GE HealthCare Technologies had its “buy” rating reaffirmed by Piper Sandler.
• 7/29/2026 – GE HealthCare Technologies had its price target raised by BTIG Research from $75.00 to $79.00. They now have a “buy” rating on the stock.
• 7/21/2026 – GE HealthCare Technologies was downgraded by Zacks Research from “hold” to “strong sell”.
• 7/17/2026 – GE HealthCare Technologies is now covered by Hovde Group. They set a “market perform” rating and a $14.00 price target on the stock.
• 7/16/2026 – GE HealthCare Technologies had its price target lowered by UBS Group AG from $69.00 to $67.00. They now have a “neutral” rating on the stock.
• 7/13/2026 – GE HealthCare Technologies had its “buy” rating reaffirmed by BTIG Research. They now have a $75.00 price target on the stock.
• 7/8/2026 – GE HealthCare Technologies is now covered by BMO Capital Markets. They set a “market perform” rating and a $70.00 price target on the stock.
• 7/8/2026 – GE HealthCare Technologies had its “neutral” rating reaffirmed by Citigroup Inc..
• 7/8/2026 – GE HealthCare Technologies was upgraded by BMO Capital Markets to “hold”.
• 6/23/2026 – GE HealthCare Technologies is now covered by Royal Bank Of Canada. They set an “outperform” rating and a $80.00 price target on the stock.
• 6/23/2026 – GE HealthCare Technologies is now covered by Royal Bank Of Canada. They set an “outperform” rating and a $80.00 price target on the stock.

GE HealthCare Technologies Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, August 14th. Investors of record on Friday, July 24th were given a dividend of $0.035 per share. The ex-dividend date of this dividend was Friday, July 24th. This represents a $0.14 dividend on an annualized basis and a yield of 0.2%. GE HealthCare Technologies’s payout ratio is 3.21%.

Insider Buying and Selling

In related news, Director Kevin Lobo purchased 10,000 shares of GE HealthCare Technologies stock in a transaction on Friday, May 22nd. The stock was purchased at an average cost of $64.18 per share, with a total value of $641,800.00. Following the acquisition, the director directly owned 14,363 shares in the company, valued at approximately $921,817.34. This trade represents a 229.20% increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is accessible through this link. 0.36% of the stock is currently owned by insiders.

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.